phosphorylethanolamine has been researched along with Hyperinsulinism in 1 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
Hyperinsulinism: A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Here, we established an in vitro hyperinsulinemia-induced IR model in the HepG2 human liver cancer cell line and primary mouse hepatocyte via a high dose of insulin treatment." | 1.91 | ETNPPL modulates hyperinsulinemia-induced insulin resistance through the SIK1/ROS-mediated inactivation of the PI3K/AKT signaling pathway in hepatocytes. ( Chen, X; Fan, X; Han, F; Huang, Y; Li, M; Li, W; Li, X; Li, Y; Liu, P; Liu, W; Qian, L; Sun, X; Wang, C; Xiong, Y; Zhang, W, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X | 1 |
| Liu, P | 1 |
| Zhang, W | 1 |
| Li, X | 1 |
| Wang, C | 1 |
| Han, F | 1 |
| Liu, W | 1 |
| Huang, Y | 1 |
| Li, M | 1 |
| Li, Y | 1 |
| Sun, X | 1 |
| Fan, X | 1 |
| Li, W | 1 |
| Xiong, Y | 1 |
| Qian, L | 1 |
1 other study available for phosphorylethanolamine and Hyperinsulinism
| Article | Year |
|---|---|
ETNPPL modulates hyperinsulinemia-induced insulin resistance through the SIK1/ROS-mediated inactivation of the PI3K/AKT signaling pathway in hepatocytes.
Topics: Animals; Diabetes Mellitus, Type 2; Hepatocytes; Humans; Hyperinsulinism; Insulin; Insulin Resistanc | 2023 |